Mr. Speaker, I was very proud to announce that along with our partners we are investing $255 million in genomics and precision medicine research through Genome Canada and the Canadian Institutes for Health Research.
The member for Willowdale is a strong advocate for improving care for Canadians, and he is right. Genomics and precision medicine have the potential to greatly improve the lives of Canadians. The research projects receiving funding will help children who are living with asthma, brain cancer, cystic fibrosis, and other rare genetic disorders.